Getting Into the Brain: The Intranasal Approach to Enhance the Delivery of Nerve Growth Factor and Its Painless Derivative in Alzheimer’s Disease and Down Syndrome
The neurotrophin Nerve Growth Factor (NGF) holds a great potential as a therapeutic candidate for the treatment of neurological diseases. However, its safe and effective delivery to the brain is limited by the fact that NGF needs to be selectively targeted to the brain, to avoid severe side effects...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2022-03-01
|
| シリーズ: | Frontiers in Neuroscience |
| 主題: | |
| オンライン･アクセス: | https://www.frontiersin.org/articles/10.3389/fnins.2022.773347/full |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|